Dr. Alexander Key is a partner in the technology transactions practice of Wilson Sonsini Goodrich & Rosati, where he focuses on the representation of biotechnology, pharmaceutical, medical device, digital health, and other life science and technology companies. Alex advises private and public companies, both domestic and international, on a broad range of partnering transactions, including the structuring and negotiation of licenses, collaborations, and procurement arrangements, as well as mergers and acquisitions. He has significant experience in novel therapeutic modalities and technologies, including AI-enabled target and drug discovery and next-generation medical devices. Alex regularly assists nonprofits with transactional and intellectual property matters, including The Buck Institute for Research on Aging, Fogarty Innovation, and Stanford Biodesign.

Alex was named as a “star” by LMG Life Sciences Americas in 2024 and was shortlisted as a finalist for “Licensing and Collaboration Attorney of the Year” in 2025.